Nasdaq Ensc News Today

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 56,500 shares, a drop of 34.4% from the February 29th total of 86,100 shares. Based on an average daily volume of 1,440,000 shares, the short-interest ratio […]

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 15th, there was short interest totalling 61,100 shares, a drop of 91.0% from the January 31st total of 678,500 shares. Based on an average daily volume of 1,500,000 shares, […]

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the target of a large increase in short interest in the month of December. As of December 15th, there was short interest totalling 167,000 shares, an increase of 25.3% from the November 30th total of 133,300 shares. Based on an average trading volume of 198,900 shares, […]

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 23,300 shares, a growth of 9.9% from the September 30th total of 21,200 shares. Approximately 0.9% of the shares of the stock are […]

Ensysce Biosciences (NASDAQ:ENSC – Free Report) had its target price lowered by HC Wainwright from $9.00 to $7.00 in a research report sent to investors on Monday morning, MarketBeat.com reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for Ensysce Biosciences’ Q3 2023 earnings at ($0.93) EPS, Q4 […]

Ensysce Biosciences (NASDAQ:ENSC – Get Free Report) and GH Research (NASDAQ:GHRS – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, analyst recommendations, risk, profitability, earnings, valuation and dividends. Valuation and Earnings This table compares Ensysce Biosciences […]

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Free Report) was the recipient of a large increase in short interest in July. As of July 31st, there was short interest totalling 44,600 shares, an increase of 81.3% from the July 15th total of 24,600 shares. Based on an average trading volume of 744,600 shares, the short-interest ratio […]

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Rating) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 113,600 shares, an increase of 43.8% from the April 30th total of 79,000 shares. Based on an average trading volume of 664,800 shares, the […]

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Rating) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 79,000 shares, a growth of 62.2% from the April 15th total of 48,700 shares. Currently, 6.3% of the company’s shares are sold short. Based on an average […]

Ensysce Biosciences, Inc. (NASDAQ:ENSC – Get Rating) was the target of a significant decrease in short interest during the month of March. As of March 31st, there was short interest totalling 46,000 shares, a decrease of 92.1% from the March 15th total of 580,700 shares. Based on an average trading volume of 214,300 shares, the […]